Landmark Bio Partners With InnDura Therapeutics to Advance Immune Cell Therapy Research

Landmark Bio and InnDura Therapeutics have announced a new collaboration to develop and execute product development, regulatory, and chemistry, manufacturing and control (CMC) strategies to progress InnDura’s lead program to the clinic.

Scroll to Top